Studies have shown that tetramethylpyrazine alleviates hyper-platelet responses and endothelial adhesion in a DM-induced prothrombotic phenotype by regulating the NLRP3 inflammasome (106). This evidence concerns the gene NLRP3 and diabetes mellitus.